Allan Capili

Allan Capili is currently the Biologics Lead at Amagma. Prior to joining Amagma, Allan served as the Director of the Antibody Platform at Voyager Therapeutics from August 2018 to October 2019. Allan has also held positions as Director at Scholar Rock from March 2015 to August 2018, Scientist II at Biogen Idec from October 2008 to March 2015, and Research Fellow at Brigham and Women's Hospital from October 2007 to September 2008. Allan began their career as a Research Fellow at Memorial Sloan-Kettering Cancer Center from September 2004 to August 2007. Throughout their career, Allan has made significant contributions to the field of biology and has been recognized as an expert in their field.

Allan Capili has a PhD in Structural Biology from the Icahn School of Medicine at Mount Sinai. Allan also has a BA in Biology & Mathematics from the University of Hawaii at Manoa.

Their manager is Tillman Gerngross, Founder & Chairman. Allan Capili works with Jennifer Dovey - Chief Scientific Officer, Nicholas Scarchilli - Chief Business Officer.